Close Menu

NEW YORK — Kantaro Biosciences said on Wednesday that its COVID-SeroKlir SARS-CoV-2 antibody test has received Emergency Use Authorization from the US Food and Drug Administration.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.